Topadur Pharma Deutschland GmbH

Systemic Sclerosis and Digital Ulcers

Clinical research is centered on the management of digital ulcers associated with systemic sclerosis, with attention to local treatment of ischemic fingertip lesions and related connective tissue disease complications.

  • Digital ulcer care
  • Systemic sclerosis
  • Ischemic wound treatment

The therapeutic focus is on wound-directed intervention in a rare autoimmune vascular condition affecting the hands.

Topical Wound Therapy

Research activity includes topical administration on ulcerated skin, with interest in local treatment approaches for lesions requiring direct wound application rather than systemic exposure.

  • Topical route of administration
  • Wound application
  • Local treatment

This area reflects a focus on therapies intended for direct contact with affected tissue at the site of ulceration.

Safety and Tolerability

The sponsor’s clinical interest includes local safety and tolerability evaluation of investigational wound treatments in patients with active ulcers.

  • Local safety
  • Tolerability assessment
  • Adverse local reactions

These studies are directed toward understanding how the treatment is accepted by ulcerated tissue under clinical use conditions.

Vascular and Wound Healing Disorders

Research interest extends to the intersection of microvascular dysfunction, ischemia, and impaired wound healing in autoimmune disease.

  • Microvascular disease
  • Ischemic lesions
  • Wound healing impairment

The clinical setting involves fingertip ulcers where tissue perfusion and healing capacity are key therapeutic concerns.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety of TOP-N53 for Treating Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    1 1
    Investigated diseases:
    France